Shanghai, China In 2016 was created Grand View Capital, which is appeared as VC. The fund was located in Asia if to be more exact in China. The main office of represented VC is situated in the Shanghai.
The overall number of key employees were 2.
The standard case for the fund is to invest in rounds with 4 partakers. Despite the Grand View Capital, startups are often financed by ZhenFund, Jubilee Capital Management, Amino Capital. The meaningful sponsors for the fund in investment in the same round are rocketship.vc, Jubilee Capital Management, Amino Capital.
For fund there is no match between the location of its establishment and the land of its numerous investments - United States. Among the most popular portfolio startups of the fund, we may highlight Menusifu. Among the most successful fund investment fields, there are Point of Sale, Restaurants.
The usual things for fund are deals in the range of 5 - 10 millions dollars. The fund is constantly included in less than 2 deals per year. The important activity for fund was in 2018.
Related Funds
| Fund Name | Location |
| Allectus Capital | Australia, New South Wales, Sydney |
| Biospring Partners | - |
| CADFEM | Farmington Hills, Michigan, United States |
| Coats plc | Hillingdon, United Kingdom, Uxbridge |
| DeGeorge Holdings | - |
| Delphi VC | New York, New York, United States |
| Elm | - |
| Essential Investment Partners | - |
| Full Tilt Capital | California, San Diego, United States |
| HORIBA | - |
| Japan startup support Association | Ikeda, Japan, Osaka Prefecture |
| Jessie International LLC | Beijing, Beijing, China |
| Magneti Marelli | Corbetta, Italy, Lombardia |
| Mountaingate Capital | Colorado, Denver, United States |
| Providian Financial | California, San Francisco, United States |
| QVIDTVM | New York, New York, United States |
| Tippet Venture Partners | California, Palo Alto, United States |
| WP Global Partners | Chicago, Illinois, United States |
| Yuanning Huizhi Investment Management | China, Hangzhou, Zhejiang |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Jimeng Intelligent | 14 Feb 2023 | Xuhui, Shanghai, China | |||
SciClone Pharmaceuticals | $134M | 19 Feb 2021 | Foster City, California, United States | ||
WePlay | $600K | 31 Dec 2020 | Santa Monica, California, United States | ||
Menusifu | $4M | 15 Oct 2018 | New York, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Jimeng Intelligent | 14 Feb 2023 | Xuhui, Shanghai, China | |||
SciClone Pharmaceuticals | $134M | 19 Feb 2021 | Foster City, California, United States | ||
WePlay | $600K | 31 Dec 2020 | Santa Monica, California, United States | ||
Menusifu | $4M | 15 Oct 2018 | New York, United States |
